Abstract: The invention relates to the use of an extract of Sextonia rubra or the constituents thereof, rubrenolide and/or rubrynolide, as an insecticide agent against mosquitoes, especially as a larvicide agent.

Abstract: The invention relates to a topical suspension formulation that includes a tetracycline, a liquid medium and a polymeric gelling agent. The tetracycline may be in the form of its pharmaceutically acceptable salts, hydrates, or polymorphs and is in a suspended form within the formulation. The liquid medium is selected such that it does not dissolve or substantially minimally dissolves the tetracycline. The gelling agent is a polymeric hydrocarbon gelling agent. Preferably, the tetracycline has a particle size of less than or equal to about 20 microns.

Abstract: Disclosed herein are compositions and methods for the treatment and management of pain in a subject comprising or consisting of topically or orally administering a therapeutic effective amount of a composition. The composition is made up of minute amounts of herbal extracts and compound mixtures to a subject. The composition includes turmeric extract, Boswellia extract, ginger extract, holy basil extract, rosemary extract, white willow extract and alpha lipolic acid each in minute amounts.

Abstract: The present invention relates to an herbal composition comprising a therapeutically effective amount of the extract of a plant belonging to Calophyllum species as an active ingredient and optionally, a pharmaceutically acceptable carrier. The present invention also relates to herbal composition comprising extract obtained from the plant Calophyllum inophyllum. The invention also relates to a process for the preparation of the extract. The invention also relates to a method for the treatment of metabolic disorders using the said composition. The present invention also relates to a composition comprising a therapeutically effective amount of extract of the plants from Calophyllum species in combination with a known therapeutically active agent for use in the treatment of metabolic disorders.

Abstract: The subject of the present invention is a cosmetic composition comprising at least one silk tree extract, one pomegranate tree extract and one peptide of sequence SEQ ID NO: 1. The subject of the invention is also a cosmetic process for combating skin aging and/or withering, comprising the topical application of the composition to the skin.

Abstract: The present invention discloses a composition for inhibiting vascular aging comprising a compound of Chemical formula 1, a derivative thereof or a pharmaceutically acceptable salt thereof as an active ingredient.

Abstract: Deodorant agents, which contain ginkgo or Phellodendron Bark or its extract as an active ingredient and which are high in safety and can radically inhibit the emission of human body malodors typified by sweat odor, especially, axillary odor.

Abstract: This invention replaces the practice of utilizing synthesized salicin compounds for use as anti-inflammatory components in topical pain relief compositions through the use of naturally occurring salicin in the form of Salix alba (white willow bark) botanicals. This invention is a compound of naturally occurring botanicals identified in the Natural Pharmacopeia as individually exhibiting anti-inflammatory and/or analgesic properties.

Abstract: Disclosed is a method for separating and purifying Ginkgolide C from root bark of ginkgo.

Abstract: The present invention provides a method and formulation for treating and preventing asteatosis or “dry ear” symptoms and inflammation. The method of the present invention comprises topically applying to the ear canal a semi-viscous diglycerin and butylene glycol polyhydroxy liquid formulation including hydrocortisone, a natural product anti-irritant, a wound healing agent, and an anti-inflammatory agent, stabilized with a cationic surfactant and a nonionic surfactant.

Abstract: Disclosed is a composition and method for its use that includes Magnolia bark extract, vitis vinifera extract, tocopherol or tocopherol acetate, and hydrogenated lecithin, lecithin, or dextrin.

Abstract: It is intended to provide a composition having an excellent anti-obesity action without potential for adverse side effects and the like even if taken for a long period of time. The composition is an anti-obesity composition containing an acacia bark derivative.

Abstract: The present invention relates generally to herbal milk replacer compositions for feeding animals, particularly young animals, and its method of making and feeding, and more particularly relates to shelf-stable and cheaper herbal milk replacer compositions for body weight gain along with overall development of calves to early complete functional maturity and also prevents any infection by acting as immunobooster. The herbal milk replacer compositions comprises effective amount of an mixture of herbal extract and/or at least one bioactive fraction from medicinal herbs and one or more additives selected from Energy Source, Protein Source, Chelated/organic Mineral Mixture, Vitamins, Salt, Toxin destroyer and Biocide; and process for the preparation of such extracts and herbal milk replacer compositions. The mixture of herbal extract comprising medicinal herbs selected from Emblica officinalis, Tinospora cordifolia, Embelia basaal, Cyprus rotundus, Asparagus racemosus and Lepidium sativam.

Abstract: The present invention relates to herbal medicinal compositions and extracts thereof for inhibiting growth of cancer cells. One of the examples described in the present invention comprises Forsythiae fructus, Menthae Herba, Gardeniae Fructus, Scutellariae Radix, Lophatheri Folium, Glycyrrhizae Radix, Rhei Rhizoma, Na2SO4, and Atractylodis Rhizoma. The residual examples are described herein.

Abstract: A formulation and method of mitigation of symptoms of patients suffering from a neurocutaneous pain syndrome by topical application of the formulation. The formulation is obtained by steeping the bark of a tree from the genus Betula in an aqueous acidified solution and then subsequent filtering, packaging and sterilization.

Abstract: A Chinese herbal medicine composition used for antiinflammation, detumescence and acesodyne, comprising first type medicinal material and second type medicinal material. The first type medicinal material includes Rhizoma Bletillae, Cortex Cinnamomi, Radix Angelicae Formosanae, Radix Angelicae Sinensis, Paeonia Lactiflora, Rhizoma Notopterygii, Radix Linderae, Glycyrrhizae, Radix Angelicae Pubescentis, and Radix Et Rhizoma Rhei. The second type medicinal material includes one, two, or three selected from the group consisting of Zingiber Officinale, Olibanum, and Myrrha. The preparation method for the Chinese herbal medicine composition includes adding the first type medicinal material and the second type medicinal material into a container with organic solvent, heating, filtering, and then condensing the filtrate into an extractum.

Abstract: A dermatological cream includes between about 8% and about 25% by weight of a healing oil; between about 3% and about 8% by weight of an herbal extract; between about 0.1% and about 0.6% by weight of vitamin E; a microencapsulated ingredient selected from the group consisting of: about 0.6% by weight capsaicin, between about 2% and about 2.5% by weight capsiscum, about 6% by weight methylsulfonylmethane, about 2% by weight collagen peptides, about 5% by weight azealic acid, between about 2% and about 15% by weight ibuprofen, between about 4% and about 10% by weight sulfur, between about 2% and about 15% by weight zinc oxide, between about 5% and about 8% by weight vitamin C, between about 0.5% and about 1% by weight vitamin A, between about 4% and about 8% by weight menthol, between about 3% and about 6% by weight camphor, about 0.5% by weight nicotinic acid, between about 3% and about 5% by weight amino acids, and between about 3% and about 6% by weight tea tree oil; and at least 43.4% by weight water.

Abstract: According to this invention there a novel herbal formulation for the prevention and management of coronary heart disease and associated CHD risk factors, comprising, preparing a hydromethanolic extract of at least two plants selected from of Withania somnifera, Costus speciosus, Hippophae rhamnoides and Terminalia arjuna at 60-80° C., maintaining the pH of the solution between 7-10, separating the active compounds chromatographically, subjecting the active compounds to the step of molecular characterization.

Abstract: The present invention relates to a composition comprising extract of the plant Ficus arnottiana. The invention also relates to a process for the preparation of the composition and to the composition for the use in the treatment of viral infections, particularly caused by herpes simplex viruses (HSV). The invention further relates to a method of treating a viral infection in a mammal comprising administering to the mammal a therapeutically effective amount of the composition.

Abstract: A method of treating a respiratory disease in an animal comprising the steps of administering to the animal an effective amount of a pharmaceutical composition comprising 1.5 parts by weight powdered fennel, 2.0 parts by weight powdered rhubarb, 1.0 part by weight powdered glycyrrhiza, 2.0 parts by weight powdered phellodendron bark, 1.0 part by weight powdered zedoary, 1.5 parts by weight powdered picrasma wood, 1.0 part by weight powdered matricaria chamomilla, 1.5 parts by weight powdered geranium herb, 1.0 part by weight powdered ginseng, 1.5 parts by weight powdered citrus unshiu peel, 1.0 part by weight powdered scutellaria root, 1.0 part by weight powdered magnolia bark, 2.0 parts by weight powdered oyster shell, 1.0 part by weight powdered cyperus rhizome, 2.0 parts by weight powdered platycodon root, 2.0 parts by weight powdered melia azedarach, 1.0 part by weight powdered cnidium rhizome, 2.0 parts by weight sodium bicarbonate and 4.

Abstract: The present invention relates to the use of a plant extract obtained from at least one plant of the Anacardiaceae family, for the preparation of a pharmaceutical composition used as a new herbal medicine for the prophylaxis and/or treatment of disorders associated with the digestive tract, and the relief of symptoms associated with these disorders. Additionally, through the scope of the present invention, the substances isolated from said extract also consist of the active ingredients of pharmaceutical compositions. A third objective of the invention is the use of said pharmaceutical compositions in the preparation of the class of herbal medicines for the prophylaxis and/or treatment of disorders associated with the digestive tract, in different stages, with posology and daily dosing.

Abstract: The present invention relates to a method for producing articles impregnated with at least one plant substance from at least one plant, characterized in that it comprises the following steps: a) Extraction and/or pressing of at least one plant (V1), or at least one part of said plant, producing a liquid plant extract (E1)) and a solid fibrous residue (R1), then b) Separation of said plant extract (E1) from said fibrous residue (R1), and c) Destructuring of said fibrous residue (R1), d) Production of a fibrous web or of an article made from the fibrous residue (R1) obtained in step c), and e) Impregnation of said fibrous residue (R1) with (i) at least said plant extract (E1), which is optionally concentrated, purified, flavored and/or fragranced, with (ii) at least one water-soluble or liposoluble plant substance isolated from said plant extract (E1), with (iii) at least one composition comprising at least one optionally concentrated, purified, flavored and/or fragranced water-soluble or liposoluble substan

Abstract: A composition for the prevention or inhibition of free radical-induced effect on the skin and/or hair comprises at least three antioxidant agents selected from the group consisting of ginkgo extract, emblica extract, dimethylmethoxy chromanol, pine bark extract, and rosemary extract.

Abstract: The present invention relates to a method for inhibition of xanthine oxidase comprising administrating an effective amount of the extracts from Acacia spp.

Abstract: A first composition including copper sulfate, citric acid, ammonium carbonate, propionic acid, Yucca schidigera extract, and antioxidants from essential oils and a second composition including sodium acid sulfate, citric acid and antioxidants from essential oils are sequentially administered to livestock through the drinking water supply to reduce the incidence of diseases such as Clostridium, E. coli and Salmonella and, thus, reliance on antibiotics to control the diseases.

Abstract: Disclosed is a method of treating telangiectasias on a person's skin comprising topically applying to skin in need of treatment a composition comprising magnolia bark extract.

Abstract: This disclosure pertains to methods of treating a neuro-inflammation disorder in a subject, comprising administering to a subject in need thereof an effective amount of a composition comprising a flavonoid, or a structurally related analogue, olive kernel extract, hydroxytyrosol, and berberine, and, optionally, one or more ingredients selected from the group consisting of a sulfated proteoglycan, oleocanthal, a CRH antagonist, S adenosylmethionine, a histamine 1 receptor antagonist, a histamine 3 receptor agonist, emu oil, oregano oil, grape seed oil, aloe extract, biotin, and selenium. Certain of the present compositions are useful in protecting against or treating neuro-inflammation associated with allergies, Alzheimer's disease (AD), atherosclerosis, asthma, Autistic Spectrum Disorders (ASD).

Abstract: An herbal cleanse formulation comprising five different herbal teas: a parasite tea, an intestinal tea, a detoxifying tea, a tonifying tea, and a relaxing tea. The parasite tea comprises areca seed, black plum, Sichuan pepper, and daikon radish. The intestinal tea comprises mountain hawthorn berry, magnolia bark, senna leaf, aloe, prunus, bitter orange, rhubarb, and licorice. The detoxifying tea comprises cyperus, Chinese angelica, trichosanthes, honeysuckle, forsythia, burdock fruit, dandelion, gardenia, coptis, and mustard seed. The tonifying tea comprises goji berries, red reishi, rehmannia, polygonum, astragalus, ginseng, codonopsis, and schizandra. The relaxing tea comprises ginger, lily bulbs, mimosa tree bark, acorus, sour jujube seeds, yuan zhi, and mint. The herbal cleanse formulation are to be taken at specific times of the day for a determined number of days in a specific protocol in conjunction with a vegan alkalinizing diet and incorporating Kundalini yoga.

Abstract: A method is described for producing an extract of Phyllanthus comprising the steps of: (a) extracting Phyllanthus components with a solvent; (b) fractionating the extract obtained in the preceding step on the basis of hydrophobicity; (c) collecting and combining fractions that correspond in hydrophobicity to elute fractions resulting from 10-50% methanol elution steps, wherein the elute fractions are obtained by low pressure vacuum liquid chromatography (VLC) using a C18 reversed-phase lipophilic column and a water/methanol gradient system, wherein the gradient system is based on an initial elution step of loading the column with 100% water, on intermediate elution steps with gradually decreasing water content and on a terminal elution step loading the column with 100% methanol; and (d) optionally drying the extract obtained in step (c).

Abstract: The invention relates to a method of treating or preventing a nitric oxide (NO)-responsive disease or disorder by administering to a subject in need thereof a composition, including foods such as confectionary and pet foods, comprising nut skins and/or a procyanidin-containing nut skins extract. Said composition may further comprise cocoa polyphenol(s) and/or L-arginine.

Abstract: The present invention relates to herbal medicinal compositions and extracts thereof for inhibiting growth of cancer cells. One of the examples described in the present invention comprises Forsythiae fructus, Menthae Herba, Gardeniae Fructus, Scutellariae Radix, Lophatheri Folium, Glycyrrhizae Radix, Rhei Rhizoma, Na2SO4, and Atractylodis Rhizoma. The residual examples are described herein.

Abstract: The present invention relates to herbal medicinal compositions and extracts thereof for inhibiting growth of cancer cells. One of the examples described in the present invention comprises Forsythiae (ructus, Menthae Herba, Gardeniae Fructus, Scutellariae Radix, Lophatheri Folium, Glycyrrhizae Radix, Rhei Rhizoma, Na2SO4, and Atractylodis Rhizoma. The residual examples are described herein.

Abstract: The present invention relates to synergic compositions incorporating agents for reducing cellulite and unaesthetic appearance associated therewith which comprise a base matrix constituted by conjugated linoleic acid (CLA), grape seed extract, beta-glucan, organic calcium and dry extract of pine bark together with complementary synergic agents of the matrix. The invention also relates to the use of such compositions and formulations containing said compositions.

Abstract: The invention discloses 5-lipoxygenase inhibitory product prepared from botanical sources. More specifically, the invention describes 5-lipoxygenase inhibitory extracts or bio-enriched extracts or fractions of Aphanamixis polystachya, methods of making 5-lipoxygenase inhibitory extract, and methods of treating and/or preventing disease conditions mediated by 5-lipoxygenase by using the said extract. The invention further discloses pharmaceutical or nutraceitical or dietary compositions containing therapeutically effective amounts of the extracts of Aphanamixis polystachya in combination with other known anti-inflammatory agents useful for oral, parenteral and topical administration.

Abstract: The invention relates to products, including foods such as confectionary and pet foods, comprising nut skins. Exemplary nut skins are peanut and almond skins. The products may also contain cocoa polyphenol and/or L-arginine, and are useful for inducing vasodilation.

Abstract: The invention relates to products, including foods such as confectionary and pet foods, comprising nut skins or polyphenol-containing nut skin extracts. Exemplary nut skins are peanut and almond skins. The products may also contain cocoa polyphenol and/or L-arginine, and are useful for inducing vasodilation.

Abstract: The invention concerns a starter composition for calves with herbal supplementation which comprises extracts or parts of medicinal herbs selected from Emblica officinalis, Tinospora cordifolia, Embelia basaal, Cyperus rotunduns, Asparagus racemosus and Lepidium sativum, and the method of production thereof.

Abstract: Compositions comprising from about 40 weight parts to about 1000 weight parts of a botanical nitrate source; from about 20 weight parts to about 500 weight parts of a botanical source of nitrite reduction activity; and from about 4 weight parts to about 100 weight parts of a nitrite salt. Methods of reducing triglycerides or reducing C-reactive protein levels are also provided.

Abstract: A first composition including copper sulfate, citric acid, ammonium carbonate, propionic acid, Yucca schidigera extract, and antioxidants from essential oils and a second composition including sodium acid sulfate, citric acid and antioxidants from essential oils are sequentially administered to livestock through the drinking water supply to reduce the incidence of diseases such as Clostridium, E. coli and Salmonella and, thus, reliance on antibiotics to control the diseases.

Abstract: The invention concerns herbal compositions which improve lactation of farmed livestock comprising an effective amount of an extract and/or at least one bioactive fraction or powder from herbs such as Asparagus, Gossypium, Foeniculum, Lepidium, Chlorophytum, Ipomoea, Withania, Leptadenia and optionally dicalcium phosphate, chelated minerals and/or mineral mixture.

Abstract: An antitussive composition is provided. A pharmaceutical composition for relieving, preventing and/or treating a cough includes a sufficient amount of the Morus australis Poir extract as an active component. The effective Morus australis Poir extract is prepared by extracting the root-bark of the Morus australis Poir with water, ethanol, acetone, ethyl acetate, or a combination thereof. The crude extract can be further fractioned by ultrafiltration or reverse phase column.

Abstract: Extract of picrorhiza kurroa plants and a process for making the same. The extract has strong anti-viral action against both DNA and RNA-based viruses, and also against bacterial, fungal and protozoan microorganisms. The extract essentially contains the lipophilic compounds occurring in the scrophulariaceae family of plants, in particular, the terpenes and fatty acids thereof. The extract may additionally contain other said lipophilic compounds and the aglycons of the glycosides occurring in said family of plants.

Abstract: A Chinese herbal medicine composition used for antiinflammation, detumescence and acesodyne, comprising first type of medicinal materials and second type of medicinal materials. The first type of medicinal materials include Rhizoma Bletillae, Cortex Cinnamomi, Radix Angelicae Formosanae, Radix Angelicae Sinensis, Paeonia Lactiflora, Rhizoma Notopterygii, Radix Linderae, Glycyrrhizae, Radix Angelicae Pubescentis, and Radix Et Rhizoma Rhei. The second type of medicinal materials is one, two or three selected from the group cosisting of Zingiber Officinale, Olibanum and Myrrha. The preparation method for the Chinese herbal medicine composition comprises the following steps: adding the first type of medicinal materials and the second type of medicinal materials into a container with organic solvent, heating, filtering, and then condensing the filtrate into an extratum.

Abstract: The invention provides improved processes for the extraction of betulin, lupeol, betulinic acid, suberinic acids, and/or other organic compounds and compositions from birch bark. In some embodiments, the birch bark can be physically processed prior to the extraction process, which can further improve the yield of the extraction. The bark processing can include, but is not limited to, one or more of pelletizing the bark, baling the bark, pucking the bark, or compressing the bark, to a form that is more dense per volume unit than prior to the processing.

Abstract: A method of obtaining one or more fractions from a plant material of Withania somnifera (WS) is disclosed. The method includes subjecting the plant material to hydro-alcoholic extraction in presence of a water-insoluble solvent to obtain at least one extract. The method further includes subjecting the at least one extract obtained from the hydro-alcoholic extraction to at least one of de-pigmentation, de-fatting and detoxification process to obtain the one or more fractions. The one or more fractions thus obtained contain Withaferin A in a concentration greater than concentrations of other pharmacologically active ingredients present in the one or more fractions. The one or more fraction thus obtained and one or more compositions containing the one or more fractions are effective in inhibiting proliferation of mammalian cancerous cells.

Abstract: A tampon has an absorbent body that absorbs liquid. The absorbent body includes, on its outer surface, an applied portion to which an agent is applied. The agent is a mixture of an active pharmaceutical ingredient, a first water-soluble carrier that carries the active pharmaceutical ingredient and is a main ingredient of the agent, and a second water-soluble carrier that carries the active pharmaceutical ingredient and has a melting point lower than that of the first water-soluble carrier.

Abstract: A method of obtaining one or more fractions from one or more plants is disclosed. The method includes subjecting one or more parts of the one or more plants to hydro-alcoholic extraction in presence of a water-insoluble solvent to obtain one or more extracts. The method further includes subjecting the one or more extracts to one or more of de-pigmentation, de-fatting and detoxification process to obtain the one or more fractions. The one or more fractions thus obtained contain a desired pharmacologically active ingredient in concentration greater than concentrations of other pharmacologically active ingredients present in the at least one fraction. Further, the one or more fractions are less toxic as compared with corresponding one or more fractions obtained by conventional methods. In addition, the one or more fractions are therapeutically more effective in various diseases as compared to one or more fractions obtained by conventional methods.

Abstract: It is intended to provide a composition which is useful in preventing or treating a tumor. The composition is a composition for the prevention and/or treatment of a tumor, containing an acacia bark derivative.

Abstract: This invention provides a method for identifying a composition of Cinnamomi and Poria. This invention further provides a composition comprising: Ramulus Cinnamomi, Poria Cortex, Moutan Radicis, Radix Paeonize Alba, and Semen Persicae. This invention provides various uses of these compositions.

Abstract: The present invention relates to an extract of a processed herbal medicinal plant and a composition for skin external application which contains the extract. More specifically, the composition for skin external application contains an extract of processed herbal medicinal plant, prepared through a method comprising the steps of: (a) processing an herbal medicinal plant by a process of boiling, steaming, roasting, baking or heating the medicinal plant or a combination of two or more of these processes; (b) obtaining an extract of the processed medicinal plant. The composition shows an improved antioxidant effect.